Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5195348
Max Phase: Preclinical
Molecular Formula: C16H10F2N4O
Molecular Weight: 312.28
Associated Items:
ID: ALA5195348
Max Phase: Preclinical
Molecular Formula: C16H10F2N4O
Molecular Weight: 312.28
Associated Items:
Canonical SMILES: O=C(Nc1nc2ccccc2[nH]1)c1cc2c(F)cc(F)cc2[nH]1
Standard InChI: InChI=1S/C16H10F2N4O/c17-8-5-10(18)9-7-14(19-13(9)6-8)15(23)22-16-20-11-3-1-2-4-12(11)21-16/h1-7,19H,(H2,20,21,22,23)
Standard InChI Key: GCKVDJPBBGKETN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 312.28 | Molecular Weight (Monoisotopic): 312.0823 | AlogP: 3.57 | #Rotatable Bonds: 2 |
Polar Surface Area: 73.57 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.97 | CX Basic pKa: 2.50 | CX LogP: 3.34 | CX LogD: 3.34 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.53 | Np Likeness Score: -1.57 |
1. Alsayed SSR, Suri A, Bailey AW, Lane S, Werry EL, Huang CC, Yu LF, Kassiou M, Sredni ST, Gunosewoyo H.. (2021) Synthesis and antitumour evaluation of indole-2-carboxamides against paediatric brain cancer cells., 12 (11.0): [PMID:34825187] [10.1039/D1MD00065A] |
Source(1):